View Future GrowthHydrapres 過去の業績過去 基準チェック /06Hydrapresの収益は年間平均-46.5%の割合で減少していますが、 Machinery業界の収益は年間 増加しています。収益は年間11.5% 1.8%割合で 減少しています。主要情報-46.51%収益成長率-42.19%EPS成長率Machinery 業界の成長12.10%収益成長率-1.76%株主資本利益率-80.09%ネット・マージン-19.45%次回の業績アップデート13 Aug 2026最近の業績更新Reported Earnings • May 21First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: zł8.04m (up 16% from 1Q 2025). Net loss: zł1.17m (loss narrowed 19% from 1Q 2025).お知らせ • Feb 10Hydrapres S.A. to Report Q4, 2025 Results on Feb 13, 2026Hydrapres S.A. announced that they will report Q4, 2025 results on Feb 13, 2026お知らせ • Nov 13Hydrapres S.A. to Report Q3, 2025 Results on Nov 14, 2025Hydrapres S.A. announced that they will report Q3, 2025 results on Nov 14, 2025Reported Earnings • Aug 19Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: zł7.77m (down 8.2% from 2Q 2024). Net loss: zł1.15m (loss narrowed 38% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Reported Earnings • Aug 19Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.46m (down 14% from 2Q 2023). Net loss: zł1.86m (loss widened 22% from 2Q 2023).Reported Earnings • Feb 16Full year 2023 earnings released: zł0.16 loss per share (vs zł0.03 loss in FY 2022)Full year 2023 results: zł0.16 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł37.7m (down 13% from FY 2022). Net loss: zł5.72m (loss widened 429% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.すべての更新を表示Recent updatesNew Risk • Jun 12New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł4.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł4.2m free cash flow). Earnings have declined by 47% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł23.4m market cap, or US$6.38m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).お知らせ • Jun 02Hydrapres S.A., Annual General Meeting, Jun 30, 2026Hydrapres S.A., Annual General Meeting, Jun 30, 2026, at 10:00 Central European Standard Time.Reported Earnings • May 21First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: zł8.04m (up 16% from 1Q 2025). Net loss: zł1.17m (loss narrowed 19% from 1Q 2025).New Risk • Feb 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 55% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł29.6m market cap, or US$8.27m).お知らせ • Feb 10Hydrapres S.A. to Report Q4, 2025 Results on Feb 13, 2026Hydrapres S.A. announced that they will report Q4, 2025 results on Feb 13, 2026分析記事 • Dec 30Here's Why Hydrapres (WSE:HPS) Can Afford Some DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...お知らせ • Nov 13Hydrapres S.A. to Report Q3, 2025 Results on Nov 14, 2025Hydrapres S.A. announced that they will report Q3, 2025 results on Nov 14, 2025New Risk • Oct 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł1.9m free cash flow). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł27.3m market cap, or US$7.53m). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).Reported Earnings • Aug 19Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: zł7.77m (down 8.2% from 2Q 2024). Net loss: zł1.15m (loss narrowed 38% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.分析記事 • Jun 19Hydrapres (WSE:HPS) Has Debt But No Earnings; Should You Worry?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Aug 19Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.46m (down 14% from 2Q 2023). Net loss: zł1.86m (loss widened 22% from 2Q 2023).お知らせ • Jun 05Hydrapres S.A., Annual General Meeting, Jun 28, 2024Hydrapres S.A., Annual General Meeting, Jun 28, 2024.New Risk • May 20New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł3.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł3.4m free cash flow). Earnings have declined by 81% per year over the past 5 years. Market cap is less than US$10m (zł16.2m market cap, or US$4.13m).Reported Earnings • Feb 16Full year 2023 earnings released: zł0.16 loss per share (vs zł0.03 loss in FY 2022)Full year 2023 results: zł0.16 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł37.7m (down 13% from FY 2022). Net loss: zł5.72m (loss widened 429% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.お知らせ • Jan 17+ 4 more updatesHydrapres S.A. to Report Q3, 2024 Results on Nov 14, 2024Hydrapres S.A. announced that they will report Q3, 2024 results on Nov 14, 2024Reported Earnings • Nov 19Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł9.08m (down 22% from 3Q 2022). Net loss: zł1.65m (loss widened zł1.57m from 3Q 2022).Reported Earnings • Aug 14Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł9.84m (down 11% from 2Q 2022). Net loss: zł1.53m (down 467% from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.お知らせ • Jun 04Hydrapres S.A., Annual General Meeting, Jun 28, 2023Hydrapres S.A., Annual General Meeting, Jun 28, 2023, at 11:00 Central European Standard Time.Reported Earnings • May 21First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: zł10.6m (down 5.1% from 1Q 2022). Net loss: zł1.09m (down zł1.19m from profit in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 18Full year 2022 earnings released: zł0.03 loss per share (vs zł0.008 profit in FY 2021)Full year 2022 results: zł0.03 loss per share (down from zł0.008 profit in FY 2021). Revenue: zł43.5m (up 34% from FY 2021). Net loss: zł1.08m (down 479% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.お知らせ • Jan 20+ 3 more updatesHydrapres S.A. to Report Fiscal Year 2022 Results on May 29, 2023Hydrapres S.A. announced that they will report fiscal year 2022 results on May 29, 2023Reported Earnings • Aug 19Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł11.0m (up 44% from 2Q 2021). Net income: zł417.4k (down 42% from 2Q 2021). Profit margin: 3.8% (down from 9.4% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 27Hydrapres S.A., Annual General Meeting, Jun 24, 2022Hydrapres S.A., Annual General Meeting, Jun 24, 2022, at 12:00 Central European Standard Time.Reported Earnings • Feb 17Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.01 (up from zł0.007 in FY 2020). Revenue: zł32.6m (up 24% from FY 2020). Net income: zł363.1k (up 42% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.お知らせ • Jan 30+ 4 more updatesHydrapres S.A. to Report Fiscal Year 2021 Results on May 27, 2022Hydrapres S.A. announced that they will report fiscal year 2021 results on May 27, 2022Reported Earnings • Aug 19Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł7.65m (up 51% from 2Q 2020). Net income: zł716.7k (up zł892.6k from 2Q 2020). Profit margin: 9.4% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 17Full year 2020 earnings released: EPS zł0.007 (vs zł0.007 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: zł26.4m (down 30% from FY 2019). Net income: zł256.3k (down 4.6% from FY 2019). Profit margin: 1.0% (up from 0.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Feb 10New 90-day high: zł0.42The company is up 15% from its price of zł0.36 on 10 November 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Machinery industry, which is up 33% over the same period.お知らせ • Jan 16+ 4 more updatesHydrapres S.A. to Report Q3, 2021 Results on Nov 10, 2021Hydrapres S.A. announced that they will report Q3, 2021 results on Nov 10, 2021Is New 90 Day High Low • Jan 07New 90-day high: zł0.40The company is up 6.0% from its price of zł0.37 on 09 October 2020. The Polish market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 22% over the same period.Is New 90 Day High Low • Oct 02New 90-day low: zł0.32The company is down 13% from its price of zł0.37 on 01 July 2020. The Polish market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 1.0% over the same period.収支内訳Hydrapres の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史WSE:HPS 収益、費用、利益 ( )PLN Millions日付収益収益G+A経費研究開発費31 Mar 2630-65031 Dec 2529-65030 Sep 2531-55030 Jun 2532-55031 Mar 2533-64031 Dec 2434-54030 Sep 2433-64030 Jun 2434-64031 Mar 2435-64031 Dec 2338-64030 Sep 2339-64030 Jun 2342-44031 Mar 2343-23031 Dec 2244-13030 Sep 224203030 Jun 223903031 Mar 223503031 Dec 213303030 Sep 213213030 Jun 213013031 Mar 212703031 Dec 202603030 Sep 202903030 Jun 203103031 Mar 203613031 Dec 193803030 Sep 193813030 Jun 193803031 Mar 194113031 Dec 184313030 Sep 184613030 Jun 184803031 Mar 1849-13031 Dec 1750-13030 Sep 1750-23030 Jun 1750-13031 Mar 175013031 Dec 1651-13030 Sep 165413030 Jun 165313031 Mar 1651-13031 Dec 155003030 Sep 1544030質の高い収益: HPSは現在利益が出ていません。利益率の向上: HPSは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: HPSは利益が出ておらず、過去 5 年間で損失は年間46.5%の割合で増加しています。成長の加速: HPSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: HPSは利益が出ていないため、過去 1 年間の収益成長をMachinery業界 ( -1.9% ) と比較することは困難です。株主資本利益率高いROE: HPSは現在利益が出ていないため、自己資本利益率 ( -80.09% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YCapital-goods 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 12:16終値2026/07/17 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Hydrapres S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 21First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: zł8.04m (up 16% from 1Q 2025). Net loss: zł1.17m (loss narrowed 19% from 1Q 2025).
お知らせ • Feb 10Hydrapres S.A. to Report Q4, 2025 Results on Feb 13, 2026Hydrapres S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
お知らせ • Nov 13Hydrapres S.A. to Report Q3, 2025 Results on Nov 14, 2025Hydrapres S.A. announced that they will report Q3, 2025 results on Nov 14, 2025
Reported Earnings • Aug 19Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: zł7.77m (down 8.2% from 2Q 2024). Net loss: zł1.15m (loss narrowed 38% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 19Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.46m (down 14% from 2Q 2023). Net loss: zł1.86m (loss widened 22% from 2Q 2023).
Reported Earnings • Feb 16Full year 2023 earnings released: zł0.16 loss per share (vs zł0.03 loss in FY 2022)Full year 2023 results: zł0.16 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł37.7m (down 13% from FY 2022). Net loss: zł5.72m (loss widened 429% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.
New Risk • Jun 12New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł4.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł4.2m free cash flow). Earnings have declined by 47% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł23.4m market cap, or US$6.38m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).
お知らせ • Jun 02Hydrapres S.A., Annual General Meeting, Jun 30, 2026Hydrapres S.A., Annual General Meeting, Jun 30, 2026, at 10:00 Central European Standard Time.
Reported Earnings • May 21First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: zł8.04m (up 16% from 1Q 2025). Net loss: zł1.17m (loss narrowed 19% from 1Q 2025).
New Risk • Feb 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 55% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł29.6m market cap, or US$8.27m).
お知らせ • Feb 10Hydrapres S.A. to Report Q4, 2025 Results on Feb 13, 2026Hydrapres S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
分析記事 • Dec 30Here's Why Hydrapres (WSE:HPS) Can Afford Some DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
お知らせ • Nov 13Hydrapres S.A. to Report Q3, 2025 Results on Nov 14, 2025Hydrapres S.A. announced that they will report Q3, 2025 results on Nov 14, 2025
New Risk • Oct 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł1.9m free cash flow). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł27.3m market cap, or US$7.53m). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).
Reported Earnings • Aug 19Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: zł7.77m (down 8.2% from 2Q 2024). Net loss: zł1.15m (loss narrowed 38% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
分析記事 • Jun 19Hydrapres (WSE:HPS) Has Debt But No Earnings; Should You Worry?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Aug 19Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.46m (down 14% from 2Q 2023). Net loss: zł1.86m (loss widened 22% from 2Q 2023).
お知らせ • Jun 05Hydrapres S.A., Annual General Meeting, Jun 28, 2024Hydrapres S.A., Annual General Meeting, Jun 28, 2024.
New Risk • May 20New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł3.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł3.4m free cash flow). Earnings have declined by 81% per year over the past 5 years. Market cap is less than US$10m (zł16.2m market cap, or US$4.13m).
Reported Earnings • Feb 16Full year 2023 earnings released: zł0.16 loss per share (vs zł0.03 loss in FY 2022)Full year 2023 results: zł0.16 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł37.7m (down 13% from FY 2022). Net loss: zł5.72m (loss widened 429% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.
お知らせ • Jan 17+ 4 more updatesHydrapres S.A. to Report Q3, 2024 Results on Nov 14, 2024Hydrapres S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
Reported Earnings • Nov 19Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł9.08m (down 22% from 3Q 2022). Net loss: zł1.65m (loss widened zł1.57m from 3Q 2022).
Reported Earnings • Aug 14Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł9.84m (down 11% from 2Q 2022). Net loss: zł1.53m (down 467% from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.
お知らせ • Jun 04Hydrapres S.A., Annual General Meeting, Jun 28, 2023Hydrapres S.A., Annual General Meeting, Jun 28, 2023, at 11:00 Central European Standard Time.
Reported Earnings • May 21First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: zł10.6m (down 5.1% from 1Q 2022). Net loss: zł1.09m (down zł1.19m from profit in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 18Full year 2022 earnings released: zł0.03 loss per share (vs zł0.008 profit in FY 2021)Full year 2022 results: zł0.03 loss per share (down from zł0.008 profit in FY 2021). Revenue: zł43.5m (up 34% from FY 2021). Net loss: zł1.08m (down 479% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.
お知らせ • Jan 20+ 3 more updatesHydrapres S.A. to Report Fiscal Year 2022 Results on May 29, 2023Hydrapres S.A. announced that they will report fiscal year 2022 results on May 29, 2023
Reported Earnings • Aug 19Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł11.0m (up 44% from 2Q 2021). Net income: zł417.4k (down 42% from 2Q 2021). Profit margin: 3.8% (down from 9.4% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 27Hydrapres S.A., Annual General Meeting, Jun 24, 2022Hydrapres S.A., Annual General Meeting, Jun 24, 2022, at 12:00 Central European Standard Time.
Reported Earnings • Feb 17Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.01 (up from zł0.007 in FY 2020). Revenue: zł32.6m (up 24% from FY 2020). Net income: zł363.1k (up 42% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
お知らせ • Jan 30+ 4 more updatesHydrapres S.A. to Report Fiscal Year 2021 Results on May 27, 2022Hydrapres S.A. announced that they will report fiscal year 2021 results on May 27, 2022
Reported Earnings • Aug 19Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł7.65m (up 51% from 2Q 2020). Net income: zł716.7k (up zł892.6k from 2Q 2020). Profit margin: 9.4% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 17Full year 2020 earnings released: EPS zł0.007 (vs zł0.007 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: zł26.4m (down 30% from FY 2019). Net income: zł256.3k (down 4.6% from FY 2019). Profit margin: 1.0% (up from 0.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Feb 10New 90-day high: zł0.42The company is up 15% from its price of zł0.36 on 10 November 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Machinery industry, which is up 33% over the same period.
お知らせ • Jan 16+ 4 more updatesHydrapres S.A. to Report Q3, 2021 Results on Nov 10, 2021Hydrapres S.A. announced that they will report Q3, 2021 results on Nov 10, 2021
Is New 90 Day High Low • Jan 07New 90-day high: zł0.40The company is up 6.0% from its price of zł0.37 on 09 October 2020. The Polish market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 22% over the same period.
Is New 90 Day High Low • Oct 02New 90-day low: zł0.32The company is down 13% from its price of zł0.37 on 01 July 2020. The Polish market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 1.0% over the same period.